We think that a deficit in PTX 3, which inhibits target cell activity by binding with high affinity to FGF2 in the gastric epithelium, thus preventing growth factor binding to receptors on the cell surface, prepares the foundation for gastric cancer development. This evidence concerns the gene FGF2 and gastric cancer.